Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $11.8800 (1.02%) ($11.6100 - $11.9300) on Sat. Aug. 19, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.26% (three month average) | RSI | 37 | Latest Price | $11.8800(1.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.1% a day on average for past five trading days. | Weekly Trend | HALO declines -3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting HALO price | HALO will decline at least -1.13% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.13% (StdDev 2.26%) | Hourly BBV | 0 () | Intraday Trend | 2% | | | |
|
1 - 5 Day Possible Target | $2.96(-75.08%) | Resistance Level | $12.59 | 5 Day Moving Average | $11.9(-0.17%) | 10 Day Moving Average | $12.21(-2.7%) | 20 Day Moving Average | $12.59(-5.64%) | To recent high | -20.2% | To recent low | 1% | Market Cap | $N/A | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |